The 36-Year Cancer Fight That Led To A Nobel Prize
Dr. Jim Allison, Chairman of Immunology at the MD Anderson Cancer Center, on winning the Nobel Prize for his cancer treatment research on immunotherapies. Duncan Wood, Director of the Mexico Institute...
2 Okt 201827min
New GE CEO Has An Uphill Battle, Needs To Shrink Power
Karen Ubelhart, Senior Industrials Analyst for Bloomberg Intelligence, on GE’s new CEO and eps guidance. Ramesh Ponnuru, Senior Editor at the National Review and Bloomberg Opinion columnist, on the Ka...
1 Okt 201820min
Tesla Will Struggle To Raise Money Without Elon: Kudla (Podcast)
David Kudla, Founder, CEO and Chief Investment Strategist of Mainstay Capital, on Tesla outlook following the SEC lawsuit against CEO Elon Musk. Former Cisco CEO John Chambers shares his playbook and ...
28 Sep 201830min
Best Technology Opportunities Lie Away From The Herd
Kevin Landis, CEO of Firsthand Technology Fund (NASDAQ: SVVC), and CIO of Firsthand Capital Management, discusses the less travelled areas of tech investing. Brad Hunter, Chief Economist at HomeAdviso...
26 Sep 201818min
Trump’s UN Address Targets Regime Change In Iran: Cohen
Ariel Cohen, Senior Fellow at the Atlantic Council, on President Trump’s address to the UN, how it will impact Iran-US relations, and what to expect from this week’s assembly. Phil Torres, Global Co-H...
25 Sep 201823min
Rosenstein Resignation Would Be Greatest Gift To Trump
Al Hunt, Bloomberg Opinion columnist, and June Grasso, June Grasso, legal analyst and co-host of Bloomberg Law, on the political and legal implications surrounding reports that Rod Rosenstein is resig...
24 Sep 201832min
Leveraged-Loan Gloom Is Way Overdone: Eaton Vance PM
Chris Remington,Director of Income Product & Portfolio Strategy at Eaton Vance, on whether investors are jumping into the leveraged loan market at the wrong time. Ian Wishart, Bloomberg European gover...
21 Sep 201825min
Get Paid, But Only For Beating Benchmarks: Peter Kraus
Peter Kraus, Founder and Partner of Aperture Investors and former CEO of AllianceBernstein, on launching a new approach to fund management: performance-based pay, and fees only if they beat the market...
20 Sep 201828min
